# TTEC Holdings, Inc.: financial statements, quarterly

TTEC · Nasdaq · CIK 1013880 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ttec.md) · [Financials](/companies/ttec/financials.md) · [Filings](/companies/ttec/filings.md) · [Insiders](/companies/ttec/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ttec/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [603](/filings/0001558370-24-014654.md) | [626 d](/filings/0001104659-26-020532.md) | [577](/filings/0001558370-25-006995.md) | [534](/filings/0001558370-25-010783.md) | [529](/filings/0001104659-25-107771.md) | [567 d](/filings/0001104659-26-020532.md) | [534](/filings/0001104659-26-057190.md) | [514](/filings/0001104659-26-093402.md) | [519](/filings/0001104659-25-107771.md) | [570 d](/filings/0001104659-26-020532.md) | [496](/filings/0001104659-26-057190.md) | [455](/filings/0001104659-26-093402.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [66.8](/filings/0001558370-24-014654.md) | [74.7 d](/filings/0001104659-26-020532.md) | [74.6](/filings/0001558370-25-006995.md) | [73.7](/filings/0001558370-25-010783.md) | [71.6](/filings/0001104659-25-107771.md) | [73.2 d](/filings/0001104659-26-020532.md) | [70.0](/filings/0001104659-26-057190.md) | [70.7](/filings/0001104659-26-093402.md) | [68.9](/filings/0001104659-25-107771.md) | [70.7 d](/filings/0001104659-26-020532.md) | [66.5](/filings/0001104659-26-057190.md) | [61.3](/filings/0001104659-26-093402.md) |
| Operating income | $m | [25.4](/filings/0001558370-24-014654.md) | [16.9 d](/filings/0001104659-26-020532.md) | [22.7](/filings/0001558370-25-006995.md) | [(224)](/filings/0001558370-25-010783.md) | [12.9](/filings/0001104659-25-107771.md) | [15.3 d](/filings/0001104659-26-020532.md) | [24.2](/filings/0001104659-26-057190.md) | [18.9](/filings/0001104659-26-093402.md) | [12.3](/filings/0001104659-25-107771.md) | [(173) d](/filings/0001104659-26-020532.md) | [18.5](/filings/0001104659-26-057190.md) | [11.0](/filings/0001104659-26-093402.md) |
| Interest expense | $m | [20.3](/filings/0001558370-23-018303.md) | [21.6 d](/filings/0001558370-24-002207.md) | [21.1](/filings/0001558370-24-007368.md) | [20.4](/filings/0001558370-24-011611.md) | [21.7](/filings/0001104659-25-107771.md) | [21.1 d](/filings/0001104659-26-020532.md) | [19.8](/filings/0001104659-26-057190.md) | [18.2](/filings/0001104659-26-093402.md) | [16.6](/filings/0001104659-25-107771.md) | [17.0 d](/filings/0001104659-26-020532.md) | [17.0](/filings/0001104659-26-057190.md) | [16.7](/filings/0001104659-26-093402.md) |
| Income tax | $m | [5.3](/filings/0001558370-24-014654.md) | [3.1 d](/filings/0001104659-26-020532.md) | [2.3](/filings/0001558370-25-006995.md) | [54.1](/filings/0001558370-25-010783.md) | [9.4](/filings/0001104659-25-107771.md) | [8.3 d](/filings/0001104659-26-020532.md) | [9.3](/filings/0001104659-26-057190.md) | [10.3](/filings/0001104659-26-093402.md) | [11.1](/filings/0001104659-25-107771.md) | [(15.9) d](/filings/0001104659-26-020532.md) | [7.8](/filings/0001104659-26-057190.md) | [8.6](/filings/0001104659-26-093402.md) |
| Net income | $m | [(1.5)](/filings/0001558370-24-014654.md) | [(9.9) d](/filings/0001104659-26-020532.md) | [(2.3)](/filings/0001558370-25-006995.md) | [(300)](/filings/0001558370-25-010783.md) | [(21.1)](/filings/0001104659-25-107771.md) | [2.0 d](/filings/0001104659-26-020532.md) | [1.4](/filings/0001104659-26-057190.md) | [(8.0)](/filings/0001104659-26-093402.md) | [(13.4)](/filings/0001104659-25-107771.md) | [(172) d](/filings/0001104659-26-020532.md) | [(7.6)](/filings/0001104659-26-057190.md) | [(15.4)](/filings/0001104659-26-093402.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001558370-24-014654.md) | not reported | [(0.05)](/filings/0001558370-25-006995.md) | [(6.30)](/filings/0001558370-25-010783.md) | [(0.44)](/filings/0001104659-25-107771.md) | not reported | [0.03](/filings/0001104659-26-057190.md) | [(0.17)](/filings/0001104659-26-093402.md) | [(0.28)](/filings/0001104659-25-107771.md) | not reported | [(0.16)](/filings/0001104659-26-057190.md) | [(0.31)](/filings/0001104659-26-093402.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001558370-24-014654.md) | not reported | [(0.05)](/filings/0001558370-25-006995.md) | [(6.30)](/filings/0001558370-25-010783.md) | [(0.44)](/filings/0001104659-25-107771.md) | not reported | [0.03](/filings/0001104659-26-057190.md) | [(0.17)](/filings/0001104659-26-093402.md) | [(0.28)](/filings/0001104659-25-107771.md) | not reported | [(0.16)](/filings/0001104659-26-057190.md) | [(0.31)](/filings/0001104659-26-093402.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [152](/filings/0001558370-23-018303.md) | [173](/filings/0001104659-26-020532.md) | [91.5](/filings/0001558370-24-007368.md) | [79.8](/filings/0001558370-24-011611.md) | [96.9](/filings/0001558370-24-014654.md) | [85.0](/filings/0001104659-26-020532.md) | [85.1](/filings/0001558370-25-006995.md) | [82.6](/filings/0001558370-25-010783.md) | [73.5](/filings/0001104659-25-107771.md) | [82.9](/filings/0001104659-26-093402.md) | [88.7](/filings/0001104659-26-057190.md) | [93.9](/filings/0001104659-26-093402.md) |
| Current assets | $m | [662](/filings/0001558370-23-018303.md) | [681](/filings/0001558370-25-001823.md) | [617](/filings/0001558370-24-007368.md) | [603](/filings/0001558370-24-011611.md) | [653](/filings/0001558370-24-014654.md) | [652](/filings/0001104659-26-020532.md) | [655](/filings/0001558370-25-006995.md) | [628](/filings/0001558370-25-010783.md) | [636](/filings/0001104659-25-107771.md) | [673](/filings/0001104659-26-093402.md) | [622](/filings/0001104659-26-057190.md) | [592](/filings/0001104659-26-093402.md) |
| Total assets | $m | [2,168](/filings/0001558370-23-018303.md) | [2,186](/filings/0001558370-25-001823.md) | [2,115](/filings/0001558370-24-007368.md) | [1,793](/filings/0001558370-24-011611.md) | [1,826](/filings/0001558370-24-014654.md) | [1,753](/filings/0001104659-26-020532.md) | [1,726](/filings/0001558370-25-006995.md) | [1,695](/filings/0001558370-25-010783.md) | [1,682](/filings/0001104659-25-107771.md) | [1,499](/filings/0001104659-26-093402.md) | [1,413](/filings/0001104659-26-057190.md) | [1,374](/filings/0001104659-26-093402.md) |
| Current liabilities | $m | [423](/filings/0001558370-23-018303.md) | [403](/filings/0001558370-25-001823.md) | [384](/filings/0001558370-24-007368.md) | [388](/filings/0001558370-24-011611.md) | [339](/filings/0001558370-24-014654.md) | [354](/filings/0001104659-26-020532.md) | [334](/filings/0001558370-25-006995.md) | [355](/filings/0001558370-25-010783.md) | [363](/filings/0001104659-25-107771.md) | [356](/filings/0001104659-26-093402.md) | [309](/filings/0001104659-26-057190.md) | [317](/filings/0001104659-26-093402.md) |
| Total liabilities | $m | [1,561](/filings/0001558370-23-018303.md) | [1,570](/filings/0001558370-25-001823.md) | [1,503](/filings/0001558370-24-007368.md) | [1,488](/filings/0001558370-24-011611.md) | [1,531](/filings/0001558370-24-014654.md) | [1,485](/filings/0001104659-26-020532.md) | [1,445](/filings/0001558370-25-006995.md) | [1,400](/filings/0001558370-25-010783.md) | [1,401](/filings/0001104659-25-107771.md) | [1,386](/filings/0001104659-26-093402.md) | [1,311](/filings/0001104659-26-057190.md) | [1,283](/filings/0001104659-26-093402.md) |
| Shareholders' equity | $m | [603](/filings/0001558370-24-014654.md) | [616](/filings/0001104659-26-020532.md) | [612](/filings/0001558370-25-010783.md) | [304](/filings/0001104659-25-107771.md) | [295](/filings/0001104659-25-107771.md) | [268](/filings/0001104659-26-093402.md) | [282](/filings/0001104659-26-093402.md) | [295](/filings/0001104659-26-093402.md) | [281](/filings/0001104659-25-107771.md) | [113](/filings/0001104659-26-093402.md) | [102](/filings/0001104659-26-093402.md) | [90.8](/filings/0001104659-26-093402.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(31.7) d](/filings/0001558370-24-014654.md) | [31.5 d](/filings/0001104659-26-020532.md) | [(15.6)](/filings/0001558370-25-006995.md) | [49.3 d](/filings/0001558370-25-010783.md) | [(91.4) d](/filings/0001104659-25-107771.md) | [(1.1) d](/filings/0001104659-26-020532.md) | [21.6](/filings/0001104659-26-057190.md) | [92.7 d](/filings/0001104659-26-093402.md) | [4.2 d](/filings/0001104659-25-107771.md) | [2.6 d](/filings/0001104659-26-020532.md) | [27.5](/filings/0001104659-26-057190.md) | [51.3 d](/filings/0001104659-26-093402.md) |
| Capital expenditure | $m | [21.8 d](/filings/0001558370-24-014654.md) | [13.1 d](/filings/0001104659-26-020532.md) | [13.5](/filings/0001558370-25-006995.md) | [14.2 d](/filings/0001558370-25-010783.md) | [8.8 d](/filings/0001104659-25-107771.md) | [8.7 d](/filings/0001104659-26-020532.md) | [5.4](/filings/0001104659-26-057190.md) | [7.2 d](/filings/0001104659-26-093402.md) | [13.8 d](/filings/0001104659-25-107771.md) | [11.7 d](/filings/0001104659-26-020532.md) | [6.4](/filings/0001104659-26-057190.md) | [12.6 d](/filings/0001104659-26-093402.md) |
| Dividends paid | $m | [0.0 d](/filings/0001558370-24-014654.md) | [24.7 d](/filings/0001104659-26-020532.md) | [0.0](/filings/0001558370-24-007368.md) | [2.8 d](/filings/0001558370-25-010783.md) | [0.0 d](/filings/0001104659-25-107771.md) | [0.0 d](/filings/0001104659-26-020532.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.3](/filings/0001558370-23-018303.md) | [47.4](/filings/0001558370-24-007368.md) | [47.5](/filings/0001558370-24-011611.md) | [47.5](/filings/0001558370-24-014654.md) | [47.6](/filings/0001558370-25-006995.md) | [47.6](/filings/0001558370-25-010783.md) | [47.7](/filings/0001104659-25-107771.md) | [48.2](/filings/0001104659-26-057190.md) | [48.1](/filings/0001104659-26-093402.md) | [48.5](/filings/0001104659-25-107771.md) | [48.6](/filings/0001104659-26-057190.md) | [48.9](/filings/0001104659-26-093402.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 49,295,940 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093402.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.